What did Getinge AB pay for Talis Clinical?

Getinge AB acquired Talis Clinical for $65.6M in 2021, equivalent to 14.90x revenue. Target revenue was approximately $4.4M.

What does Talis Clinical do?

Talis Clinical is a healthcare it business.

What multiple did Getinge AB pay for Talis Clinical?

14.90x revenue, based on disclosed deal value of $65.6M and disclosed financials.

M&A TRANSACTION · 2021

Talis Clinical acquired by Getinge AB

$65.6M· 14.90x revenue

Target

Talis Clinical

Acquirer

Getinge AB

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$4.4M

EBITDA

—

Deal Value

$65.6M

EV/EBITDA

—

Context

This $65.6M acquisition of Talis Clinical by Getinge AB sits in the healthcare it sub-vertical. Getinge AB is acquiring as a strategic buyer; see how strategic acquirers typically price healthcare it businesses on our Healthcare It strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own healthcare it

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Talis Clinical acquisition.

Citation: ExitValue.ai. (2021). Talis Clinical acquired by Getinge AB. https://exitvalue.ai/deals/talis-clinical-acquired-by-getinge-ab-hc-2021-0078